Merck and the National Sleep Foundation Urge Insomnia Sufferers to Prioritize Sleep and MoveBeyond Tired
FDA APPROVES IMLYGIC™ (TALIMOGENE LAHERPAREPVEC) AS FIRST ONCOLYTIC VIRAL THERAPY IN THE US
U.S. FDA APPROVES BELBUCA™(BUPRENORPHINE) BUCCAL FILM FOR CHRONIC PAIN MANAGEMENT
Iroko Pharmaceuticals Receives FDA Approval for VIVLODEX™ - First Low Dose SoluMatrix®Meloxicam for Osteoarthritis Pain
VolitionRx Demonstrates NuQ® Blood Test Detects 95% of Pancreatic Cancers in Second Preliminary Study
Abbott Teams Up with Soccer Star Cristiano Ronaldo to Inspire Young People to Donate Blood
Merrimack Announces U.S. FDA Approval of ONIVYDE™ (irinotecan liposome injection) for the Treatment of Patients with Metastatic Pancreatic Cancer
AMGEN FOUNDATION ANNOUNCES NEW $4 MILLION COMMITMENT TO BRING HANDS-ON BIOTECHNOLOGY LABS TO SECONDARY SCHOOL STUDENTS
23andMe Launches New Customer Experience - Reports Include Carrier Status That Meet FDA Standards, Wellness, Traits, and Ancestry
Metastatic Breast Cancer Alliance Launches New Public Awareness Campaign Focusing on Lack of Understanding of Metastatic Breast Cancer
Philips Sonicare teams up with its toughest critic yet - kids - to put its newest power toothbrush and connected app to the test
BOSTON SCIENTIFIC RECEIVES FDA APPROVAL FOR SYNERGY™ BIOABSORBABLE POLYMER DRUG-ELUTING STENT SYSTEM
INVUITY® LAUNCHES HIDDEN SCAR™PROGRAM FOR BREAST CANCER SURGERY AT AMERICAN COLLEGE OF SURGEONS (ACS) ANNUAL CLINICAL CONGRESS 2015
Sanofi Announces Launch of Authorized Generic Version of Arava® (Leflunomide) Tablets
Public Urged to #CutTheBull and Get Involved
The Leukemia & Lymphoma Society Commits $28.6 Million to New Cancer Research Funding
FROM STATUS QUO TO ACTION ON ADVANCED ILLNESS CARE
CYCLE FOR SURVIVAL LAUNCHES 2016 EVENT REGISTRATION WITH A SEA OF STATIONARY BIKES IN TIMES SQUARE
Gout and Elevated Uric Acid Are Linked to Several Serious Health Risks - Yet Few Americans Understand the Connection
American Heart Association launches new national initiative with goals to target growing impact of heart failure
BOSTON SCIENTIFIC LAUNCHES THE CAPTIVATOR™ EMR DEVICE TO TREAT DISEASES OF THE UPPER GI TRACT
ELUVIA™ DRUG-ELUTING VASCULAR STENT SYSTEM DEMONSTRATES 12-MONTH PRIMARY PATENCY OF 96.1 PERCENT
TAILORx trial finds 99 percent of women with low Oncotype DX® Recurrence Score®are free of breast cancer recurrence after five years of hormone therapy alone
Supergoop! Co-Owner Maria Sharapova and Founder & CEO Holly Thaggard Announce the Launch of Project Black Dot
Mead Johnson Helps Advance the Nutritional Care for Preterm Infants
|
|
The message is clear Multimedia public relations is not just the wave of the future. It’s the reality of today.
|